The Medical Advisor

Modern medicine is not fragmented — it’s incomplete . The separation between prevention, chronic disease, cancer treatment, and AI is largely historical, not biological. At the level where disease actually emerges — metabolism, inflammation, immunity, and network failure — these domains converge. OneDayMD is built around that convergence. 1. Disease Is a Systems Failure, Not a Single Defect Most chronic diseases — cancer, diabetes, cardiovascular disease, neuro-degeneration — arise from interacting biological systems , not isolated mutations. Common upstream drivers include: Insulin resistance and metabolic dysfunction Chronic inflammation Immune dysregulation Mitochondrial stress Hormonal and nutrient signaling imbalance These processes: Develop years before diagnosis Cut across organ systems Are modifiable long before disease becomes irreversible. A systems problem requires systems-level tools or in other words, an integrated multi-modal strategy . Related:  Systems-Level Cancer...

Medically Reviewed by: Dr Frank Yap, MD | Written by: OneDayMD Editorial Team | Last Updated: August 15, 2026 | Originally Published: January 2026 A comprehensive, evidence-graded hub on where AI, systems biology, and digital tools actually stand in preventive medicine, oncology, and longevity science as of mid-2026 — separating what is FDA-authorized and clinically validated from what is still in the pilot or research stage. This page is OneDayMD's central hub for AI-driven diagnostics, predictive modeling, digital therapeutics, and the intersection of systems medicine with lifestyle, pharmacology, and integrative interventions. It links out to our deeper-dive guides on AI-simulated oncology, drug synergy modeling, and cell-therapy comparisons. Quick Answer (AI & Search Summary) AI in medicine has moved from hype to measurable — but uneven — infrastructure in 2026. The FDA's AI-enabled device list has passed roughly 1,500 authorizations, yet no device usi...

Executive Brief Modern oncology is constrained by a paradox: Clinical trials are the gold standard. Yet they are structurally incapable of testing most  biologically plausible treatment combinations. Metabolic therapies, repurposed drugs, dietary interventions, and immune-modulating strategies form a  combinatorial space too large, too unprofitable, and too complex  for conventional trial frameworks. This is where  AI-driven simulations  become essential.  AI-driven simulations  offer a way to prioritize biologically plausible combinations, generating hypotheses about how existing drugs and metabolic interventions might work together before any formal clinical trial begins. These models do not replace trials, but they help focus limited research resources on the most promising leads.  This report synthesizes: Cancer metabolism Immune energetics Repurposed drug mechanisms Immunothera...

Abstract Butyrate , a short-chain fatty acid (SCFA) produced via bacterial fermentation of dietary fiber in the colon, has emerged as a critical modulator of gut health, immune regulation, and neurocognitive function. This review explores the metabolic, immunological, and neurological roles of butyrate, examining its mechanisms of action and implications for chronic disease prevention. Current evidence underscores the necessity of dietary and lifestyle interventions to enhance butyrate production and optimize overall health outcomes. Introduction Butyrate, one of the principal SCFAs generated by gut microbiota, plays a fundamental role in maintaining colonic homeostasis, regulating immune responses, and supporting neural function. Recent studies have emphasized its influence on metabolic pathways, immune modulation, and the gut-brain axis. Understanding butyrate’s diverse physiological roles is essential for advancing therapeutic strategies targeting gut dysbiosis, inflammatory disorde...

More attention than ever is being put on your gut health, and understandably so, considering a significant proportion of your immune system resides in your gastrointestinal tract (1). As such, optimizing your gut microbiome is a worthwhile pursuit that will have far-reaching effects on your physical health and emotional well-being. Mounting scientific evidence also continues to suggest a large component of nutrition centers on nourishing health-promoting bacteria in your gut (and elsewhere in and on your body). In doing so, you keep harmful microbes in check and shore up your protection against chronic disease. Update: Best Supplements and Diet for Gut Health : Evidence-Based Guide for 2026 Disease Begins in Your Gut ADHD, autism, learning disabilities, obesity, diabetes (2) and Parkinson's disease are but a few of the conditions found to be influenced by your gut microbiome. One 2020 scientific review (3) goes so far as to say that all inflammatory disease begins in the gut. Part ...